Everolimus Tablet
Product Images NDC 82293-030

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 82293-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novugen Pharma (usa) Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10's Blister Label (10 mg 10 Blister)

Everolimus 10 mg tablet packaging label showing individual tablet blisters. Each section includes the product name everolimus tablet 10 mg, storage instructions, Rx only designation, manufacturer Novugen Pharma (USA) LLC, and indicates the product is made in Malaysia. The label also includes NDC 82293-033-30 and a barcode.*

FDA Label Image

28' Tablets Carton (10 mg 28 Tablets Carton)

Packaging label for Everolimus Tablets 10 mg oral tablets by Novugen Pharma (USA) LLC. The carton contains 28 tablets, arranged as 4 blister cards of 7 tablets each. The label states the dosage strength of 10 mg per tablet and provides storage instructions, distributor address, and barcode.*

FDA Label Image

30' Tablets Carton (10 mg 30 Tablets Carton)

Everolimus Tablets 10 mg oral tablets packaging label from Novugen Pharma (USA) LLC. The carton contains 30 tablets in 3 blister cards of 10 tablets each. The label includes storage instructions, distributor address, and indicates the product is prescription only. The NDC number 82293-033-31 is shown along with a barcode.*

FDA Label Image

7's Blister Label (10 mg 7 Blister)

Label sheet for Everolimus Tablet 10 mg oral tablets from Novugen Pharma (USA) LLC. Each label includes the product name, strength, dosage form, storage instructions, distributor information, barcode, and lot/expiration placeholders. Labels indicate the tablets are prescription-only and made in Malaysia. The sheet includes multiple copies and one cavity marked EMPTY CAVITY.*

FDA Label Image

Container Label (10 mg Container Label)

Everolimus Tablets 10 mg oral tablet label showing 28 tablets per package. The label includes storage instructions, manufacturer Novugen Pharma (USA) LLC, and the product is made in Malaysia. It features a barcode and a designated varnish area for packaging.*

FDA Label Image

Pouch Label (10 mg Pouch Label)

Everolimus Tablets 10 mg oral tablets in a pouch containing 30 tablets, packaged as 3 individual blister cards of 10 tablets each. Label shows the product is distributed by Novugen Pharma (USA) LLC, with storage instructions and a note for prescription use only. The label states the tablets contain 10 mg of everolimus, USP and are made in Malaysia.*

FDA Label Image

10's Blister Label (2 5 10 Blister)

Everolimus Tablet 2.5 mg oral tablets packaging label distributed by Novugen Pharma (USA) LLC, made in Malaysia. The label includes storage instructions specifying 20°C to 25°C (68°F to 77°F) with permitted excursions, and advises to store in the original container, protecting from light and moisture. The label displays the NDC code 82293-030-30, barcodes, and dosage strength prominently.*

FDA Label Image

28' Tablets Carton (2 5 28 Tablets Carton)

Everolimus Tablets 2.5 mg oral tablets packaging label from Novugen Pharma (USA) LLC. The carton contains 28 tablets arranged in 4 individual blister cards of 7 tablets each. The label includes storage instructions, dosage note, and distributor information, stating the product is made in Malaysia. Barcode and NDC 82293-030-21 are visible.*

FDA Label Image

30' Tablets Carton (2 5 30 Tablets Carton)

Packaging label for Everolimus Tablets 2.5 mg from Novugen Pharma (USA) LLC. The label states each tablet contains 2.5 mg everolimus, USP. The carton contains 30 tablets in three blister cards of 10 tablets each. It includes storage instructions and the distributor's address in Princeton, NJ, with the product made in Malaysia. The NDC on the package is 82293-030-31.*

FDA Label Image

7's Blister Label (2 5 7 Blister)

Packaging label for Everolimus Tablet 2.5 mg by Novugen Pharma (USA) LLC. The label includes dosing strength and storage instructions at 20ºC to 25ºC, with protection from light and moisture. It features NDC 82293-030-20 and a barcode, states 'Rx only,' and indicates the product is made in Malaysia.*

FDA Label Image

Container Label (2 5 Container Label)

Label for Everolimus Tablets 2.5 mg oral tablets by Novugen Pharma (USA) LLC, containing 28 tablets for prescription use only. The label includes storage instructions, dosage directions referencing the package insert, and a barcode on the right side. The product is made in Malaysia.*

FDA Label Image

Pouch Label (2 5 Pouch Label)

Everolimus Tablets 2.5 mg oral tablets in a pouch containing 30 tablets supplied as 3 blister cards of 10 tablets each. The label shows the manufacturer as Novugen Pharma (USA) LLC, with storage instructions and usage directions. The product is made in Malaysia and is prescription only.*

FDA Label Image

Container Label (5 Container Label)

Everolimus Tablets 5 mg oral tablet label showing a 28-tablet bottle package from Novugen Pharma (USA) LLC. The label includes storage instructions, dosage direction to see package insert, is marked Rx only, and states the product is made in Malaysia. A barcode and space for serialization data are also visible.*

FDA Label Image

10's Blister Label (5 mg 10 Blister)

Sheet of Everolimus 5 mg tablets labels from Novugen Pharma (USA) LLC. Each label shows Everolimus Tablet 5 mg with storage instructions, manufacturer information, barcode, and NDC 82293-031-30. The label notes prescription use only and manufacturing in Malaysia.*

FDA Label Image

28' Tablets Carton (5 mg 28 Tablets Carton)

The image shows the packaging label for Everolimus Tablets 5 mg by Novugen Pharma (USA) LLC. The carton contains 28 tablets, with the box indicating that each tablet contains 5 mg of everolimus USP. The box includes storage instructions, dosage directions to refer to the package insert, and states the product is for oral use and Rx only. It also notes the product is made in Malaysia and distributed by Novugen Pharma.*

FDA Label Image

30' Tablets Carton (5 mg 30 Tablets Carton)

Box packaging label for Everolimus Tablets 5 mg, an oral prescription drug by Novugen Pharma (USA) LLC. The carton contains 30 tablets, arranged as 3 blister cards of 10 tablets each. The label includes storage instructions and the product is made in Malaysia. It displays the NDC 82293-031-31 and dosage form details.*

FDA Label Image

7's Blister Label (5 mg 7 Blister)

Packaging label for everolimus tablets, showing multiple panels primarily for the 5 mg strength and one panel for the 6 mg strength. The label includes storage instructions, distributor information (Novugen Pharma USA LLC), barcode, NDC 82293-031-20, and indicates the product is made in Malaysia. The 5 mg tablets are prominently displayed across most label sections.*

FDA Label Image

Pouch Label (5 mg Pouch Label)

Everolimus Tablets 5 mg oral dosage form, each tablet containing 5 mg of everolimus USP. Packaged as 30 tablets in a pouch with 3 blister cards of 10 tablets each. Distributed by Novugen Pharma (USA) LLC, Princeton, NJ, USA, and made in Malaysia. Storage instructions and dosage directions are also provided on the label.*

FDA Label Image

10's Blister Label (7 5 mg 10 Blister)

Everolimus Tablet 7.5 mg oral tablets label from Novugen Pharma (USA) LLC. The label includes storage instructions specifying a temperature range of 20°C to 25°C (68°F to 77°F) with permitted excursions. It states the product is made in Malaysia and contains barcodes and NDC 82293-032-30.*

FDA Label Image

28' Tablets Carton (7 5 mg 28 Tablets Carton)

Box packaging label for Everolimus Tablets 7.5 mg, containing 28 tablets distributed in 4 blister cards of 7 tablets each. The label shows the active ingredient everolimus USP per tablet, indicates oral use, and includes storage instructions. The product is labeled by Novugen Pharma (USA) LLC, with manufacturing noted in Malaysia, and displays an NDC barcode.*

FDA Label Image

30' Tablets Carton (7 5 mg 30 Tablets Carton)

Packaging label for Everolimus Tablets 7.5 mg oral tablets. The label states each tablet contains 7.5 mg everolimus, USP. The carton contains 30 tablets distributed in 3 blister cards of 10 tablets each. The labeler is Novugen Pharma (USA) LLC. Storage and usage instructions, barcode, and lot information areas are visible. The product is made in Malaysia.*

FDA Label Image

7's Blister Label (7 5 mg 7 Blister)

This image shows multiple printed labels for Everolimus Tablet 7.5 mg. Each label includes storage instructions, the labeler Novugen Pharma (USA) LLC, and indicates the product is made in Malaysia. The labels display the NDC number 82293-032-20, barcode, lot and expiration placeholders, and a notation for prescription use only.*

FDA Label Image

Container Label (7 5 mg Container Label)

Label for Everolimus Tablets 7.5 mg, showing a package containing 28 tablets. The label includes storage instructions, dosage note to see package insert, barcodes, and distributor information for Novugen Pharma (USA) LLC. The product is made in Malaysia and is for oral use only.*

FDA Label Image

Pouch Label (7 5 mg Pouch Label)

Label for Everolimus Tablets 7.5 mg, containing 7.5 mg of everolimus per tablet. The package includes 30 tablets organized in three blister cards of 10 tablets each. Distributed by Novugen Pharma (USA) LLC, the label provides storage instructions and states the product is for oral use and prescription only.*

FDA Label Image

Figure (Figure01)

A Kaplan-Meier survival curve showing progression-free survival probability (%) over time in months for patients treated with everolimus 10 mg plus exemestane compared to placebo plus exemestane. The chart includes hazard ratio, confidence interval, median survival times, and log-rank p-value for statistical comparison.*

FDA Label Image

Figure (Figure03)

A Kaplan-Meier survival curve comparing the probability (%) of being event-free over time (months) between two groups: Everolimus plus best supportive care (BSC) and placebo plus BSC. The graph includes the number of patients still at risk at various time points for both groups, showing higher event-free probabilities with Everolimus plus BSC over 30 months.*

FDA Label Image

Structural (Structure0001)

Chemical structure of everolimus, showing the detailed molecular arrangement of atoms and bonds in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.